Dashboard
Portfolios
Watchlist
Community
Discover
Screener
Narratives
Your Valuation
Community
/
United States
/
Pharmaceuticals & Biotech
Create a narrative
Plus Therapeutics Community
NasdaqCM:PSTV Community
1
Narratives
written by author
0
Comments
on narratives written by author
8
Fair Values set
on narratives written by author
Create a narrative
Plus Therapeutics
Popular
Undervalued
Overvalued
Community Investing Ideas
Plus Therapeutics
AN
AnalystConsensusTarget
Consensus Narrative from 3 Analysts
15 Million Financing And Oncology Trials Will Secure Clinical Progress
Key Takeaways Strengthened financial position and leadership could drive clinical advancements, potentially boosting future revenue and improving earnings growth. Advancements and strategic partnerships indicate significant market opportunities, enhancing revenue potential and profit margins through reduced costs and expanded markets.
View narrative
US$9.63
FV
94.1% undervalued
intrinsic discount
83.21%
Revenue growth p.a.
Set Fair Value
0
users have liked this narrative
0
users have commented on this narrative
1
users have followed this narrative
7 days ago
author updated this narrative
Your Valuation for
PSTV
PSTV
Plus Therapeutics
Your Fair Value
US$
Current Price
US$0.56
85.8% undervalued
intrinsic discount
Growth estimate over
Annual revenue growth rate
5 Years
time period
%/yr
Decrease
Increase
Past
Future
-39m
61m
2015
2018
2021
2024
2025
2027
2030
Revenue US$61.3m
Earnings US$12.4m
Advanced
Set Fair Value